Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 36 for “"Avastin"”.

  1. Φαρμακοκινητική της ενδοϋαλοειδικής χορήγησης του Avastin (bevacizumab) σε κονίκλους

    … pharmacokinetics of intravitreal injection of Avastin in rabbits. Avastin is a very important drug in Ophthalmology today. The right eye of 20 rabbits was injected intravitreally with 1.25 mg/0.05 ml Avastin. Both eyes of four rabbits each time were enucleated at days 1, 3, 8, 15 and 29. …

    greece Repository record for Φαρμακοκινητική της ενδοϋαλοειδικής χορήγησης του Avastin (bevacizumab) σε κονίκλους (opens in a new tab)

  2. Ιστοπαθολογική μελέτη της ενδοϋαλοειδικής χορήγησης του Avastin (bevacizumab) σε κονίκλους

    … 1.25 mg or 2.5 mg of intravitreal bevacizumab (Avastin) revealed no important histological changes in all the anatomical parts that were examined. There were no signs of necrosis or degeneration of the retina. Retinal thickness was unchangeable in all specimens. None of the left eyes had any …

    greece Repository record for Ιστοπαθολογική μελέτη της ενδοϋαλοειδικής χορήγησης του Avastin (bevacizumab) σε κονίκλους (opens in a new tab)

  3. Erfahrungen mit intravitrealem Bevacizumab (Avastin®) bei exsudativer, altersabhängiger Makuladegeneration

    … med. Erfahrungen mit intravitrealem Bevacizumab (Avastin®) bei exsudativer, altersabhängiger Makuladegeneration eingereicht von Roland Gib, geboren am 17.01.1981 in Homburg/Saar angefertigt an der: Klinik und Poliklinik für Augenheilkunde der Universität Leipzig betreut von: Prof. Dr. med. Peter …

    qucosa-diss

  4. Μελέτη της ενδοφλέβιας και ενδοφθάλμιας συγκέντρωσης του Avastin μετά από ενδοϋαλοειδική χορήγηση στον έτερο οφθαλμό: πειραματική μελέτη σε κονίκλους

    … with great accuracy the pharmacokinetics of Avastin, in the left eye and serum, after intravitreal injection of 1.25 mg/0.05 ml Avastin in the right eye in rabbits. Avastin is a very important drug in Ophthalmology today. The right eye of 20 rabbits was injected intravitreally with 1.25 …

    greece Repository record for Μελέτη της ενδοφλέβιας και ενδοφθάλμιας συγκέντρωσης του Avastin μετά από ενδοϋαλοειδική χορήγηση στον έτερο οφθαλμό: πειραματική μελέτη σε κονίκλους (opens in a new tab)

  5. Examining Cellular Interactions and Response to Chemotherapy in The Glioblastoma Perivascular Niche

    … of chemotherapeutic drugs temozolomide (TMZ) and Avastin® on EC networks, LN229 cell morphology and alignment, cytotoxicity, colocalization, and trans-differentiation. TMZ was observed to primarily affect LN229 cells, with treatment at high concentrations resulting in up to 2.3-fold reduced …

    vt Repository record for Examining Cellular Interactions and Response to Chemotherapy in The Glioblastoma Perivascular Niche (opens in a new tab)

  6. Η επίδραση της bevacizumab στην επούλωση των αναστομώσεων του παχέος εντέρου: πειραματική μελέτη σε επίμυες

    … a solution of the substance bevacizumab (Avastin, Roche Pharma AG, Grenzach-Wyhlen, Germany) in a single dose of 5 mg/kg of body weight was administered intraperitoneally. The C and D groups were the control groups. In these groups instead of the above mentioned bevacizumab solution, only …

    greece Repository record for Η επίδραση της bevacizumab στην επούλωση των αναστομώσεων του παχέος εντέρου: πειραματική μελέτη σε επίμυες (opens in a new tab)

  7. Αξιολόγηση της ιδιοπαθούς υπέρτασης σε ασθενείς που λαμβάνουν μπεβασιζουμάμπη

    Σκοπός: Το bevacizumab (Avastin) είναι ένα μονοκλωνικό αντίσωμα (IgG1) που παρεμποδίζει τη δράση του αγγειακού ενδοθηλιακού αυξητικού παράγοντα (VEGF) μέσω της αναστολής της σύνδεσής του με τους υποδοχείς του, παρεμβαίνοντας στην αγγειογένεση. Ο στόχος της παρούσας εργασίας είναι να αξιολογήσει την …

    athens Repository record for Αξιολόγηση της ιδιοπαθούς υπέρτασης σε ασθενείς που λαμβάνουν μπεβασιζουμάμπη (opens in a new tab)

  8. Einfluss von Pigmentepithelabhebungen auf das morphologische und funktionelle Ergebnis nach Vitrektomie mit subretinaler Ko-Applikation von rtPA und Avastin und intravitrealer Gaseingabe bei exsudativer altersbedingter Makuladegeneration mit submakulärer Blutung

    Die altersbedingte Makuladegeneration (AMD) ist die häufigste Erblindungsursache bei älteren Menschen in den westlichen Industrienationen. Durch degenerative Veränderungen am hinteren Augenpol kommt es hierbei zu einem Verlust der zentralen Sehschärfe. Es gibt eine „nicht-exsudative“ und eine …

    cau-kiel Repository record for Einfluss von Pigmentepithelabhebungen auf das morphologische und funktionelle Ergebnis nach Vitrektomie mit subretinaler Ko-Applikation von rtPA und Avastin und intravitrealer Gaseingabe bei exsudativer altersbedingter Makuladegeneration mit submakulärer Blutung (opens in a new tab)

  9. A comparison of structural and functional outcomes in patients treated with aflibercept or bevacizumab

    … or Eylea, and bevacizumab, also known as Avastin. This retrospective cohort study aims to compare the outcomes of patients treated with either Avastin or Eylea, and to observe what structural or functional changes occur in each sample. METHODS: This study included twelve eyes of 8 eligible …

    bu Repository record for A comparison of structural and functional outcomes in patients treated with aflibercept or bevacizumab (opens in a new tab)

  10. Manipulating antibody-antigen interactions in microporous membranes for selective antibody and protein purification

    … captured 8.40 mg of Herceptin and 9.96 mg of Avastin per mL of membrane. The antibodies eluted in 100 mM Gly (pH 2.7), but the membranes were not reusable. K19-modified membranes capture 16.3 mg of Herceptin per mL of membrane and showed minimal binding of Avastin, as expected because K19 …

    msu Repository record for Manipulating antibody-antigen interactions in microporous membranes for selective antibody and protein purification (opens in a new tab)

  11. Converting Therapeutic Monoclonal Antibodies into Functional VH Domains

    … two top-selling therapeutic monoclonals, namely, Avastin and Herceptin. Using error-prone PCR, libraries with variable mutation rates were constructed and displayed on phage. Careful adjustments of mutation rate in combination with optimized affinity-based selection methods led to the isolation of …

    unsw Repository record for Converting Therapeutic Monoclonal Antibodies into Functional VH Domains (opens in a new tab)

  12. Exploring the tumour microenvironment with non-invasive Magnetic Resonance Imaging techniques

    … of drug. HPG-GdF was then applied to show that Avastin (an antiangiogenic agent) decreased vessel permeability in tumours. Using histological methods, a dramatic reduction in hypoxia (oxygen deficiency in tissues) was observed in treated tumours. Unfortunately, existing MRI methods to evaluate …

    ubc Repository record for Exploring the tumour microenvironment with non-invasive Magnetic Resonance Imaging techniques (opens in a new tab) Download PDF for Exploring the tumour microenvironment with non-invasive Magnetic Resonance Imaging techniques (opens in a new tab)

  13. Retrospektive Studie zur Wirksamkeit der intravitrealen Bevacizumabbehandlung bei diabetischer Retinopathie und retinalem Venenverschluss

    … der Augenheilkunde ist es v.a. das Bevacizumab (Avastin ®), welches bei verschiedenen Krankheitsbildern eingesetzt wird, um den Verlust an Sehschärfe zu bekämpfen, der u.a. durch eine Vergrößerung der Netzhautdicke zustande kommt. Diese Arbeit untersucht die Veränderungen von Visus und …

    qucosa-diss

  14. Combined Cell and Gene Therapy Towards the Treatment of Age-related Macular Degeneration and Diabetic Retinopathy

    … retinopathy. Current anti-VEGF treatments (e.g. Avastin) can improve visual function but only temporarily and therefore patients require monthly eye injections. In addition, the anti-VEGF therapies cause side effects such as stroke, gastrointestinal perforations and bleeding. To address these …

    toronto-retro Repository record for Combined Cell and Gene Therapy Towards the Treatment of Age-related Macular Degeneration and Diabetic Retinopathy (opens in a new tab)

  15. CYTOTOXICITY OF Se-LABELED ANTIBODIES AND SELENOFOLATE AGAINST TRIPLE NEGATIVE BREAST CANCER CELL LINES MDA-MB-231 AND MDA-MB-468

    … clinical monoclonal antibodies; Herceptin® or Avastin® were covalently labeled with redox selenium and used to treat two TNBC cell lines (MDA-MB-231 and MDA-MB-468 cells) and HME50-5E cells in culture. All the three cell lines were treated with vehicle control, Selenite, increasing …

    ttu Repository record for CYTOTOXICITY OF Se-LABELED ANTIBODIES AND SELENOFOLATE AGAINST TRIPLE NEGATIVE BREAST CANCER CELL LINES MDA-MB-231 AND MDA-MB-468 (opens in a new tab)

  16. Structural Mass Spectrometry Analysis of RNA Chaperones and Protein Therapeutics

    … the biosimilarity between a biological drug, Avastin, and its biosimilar in pre-clinical development. Work was done to test the structural similarity between the two drugs and the batch-to-batch variability of the biosimilar. Structural MS proved to be an effective technique in the rapid and …

    york Repository record for Structural Mass Spectrometry Analysis of RNA Chaperones and Protein Therapeutics (opens in a new tab)

  17. Die Rolle von löslichen Faktoren bei der Hemmung der T-Zell-Aktivierung durch humane retinale Pigmentepithelzellen

    … antiangiogenetischen Medikamente Bevacizumab (Avastin™, Roche) und Ranibizumab (Lucentis™, Novartis) auf die Hemmung der T-Zell-Proliferation durch humane RPE-Zellen geprüft. <br>Methode: Humane T-Lymphozyten von verschiedenen Spendern wurden in Ko-Kulturen mit den humanen RPE-Zelllinien …

    freiburg-diss Repository record for Die Rolle von löslichen Faktoren bei der Hemmung der T-Zell-Aktivierung durch humane retinale Pigmentepithelzellen (opens in a new tab)

  18. An exploration of the effects of bevacizumab on the corneal epithelium and endothelium : an in vitro and clinical study

    … widely used therapeutic agent is bevacizumab (Avastin®), a full-length recombinant humanized monoclonal antibody against VEGF, due to its cost-effectiveness. Despite the widespread use of bevacizumab in ophthalmology, its use is considered off-label. Therefore, ongoing studies into the safety …

    ubc Repository record for An exploration of the effects of bevacizumab on the corneal epithelium and endothelium : an in vitro and clinical study (opens in a new tab) Download PDF for An exploration of the effects of bevacizumab on the corneal epithelium and endothelium : an in vitro and clinical study (opens in a new tab)

  19. Monoclonal Antibody Expression and Novel Purification in Nicotiana benthamiana

    … $1 billion/year), include antibodies such as Avastin (bevacizumab), Herceptin (trastuzumab), Rituxan (rituximab), Humira (adalimumab) and Remicade (infliximab), which are cornerstones in this type of sector. With the cost of development to market approval rising astronomically for a new drug, …

    vt Repository record for Monoclonal Antibody Expression and Novel Purification in Nicotiana benthamiana (opens in a new tab)

Page 1 of 2